View in EDS HTML Full Text PDF Full Text

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.

Saved in:
Bibliographic Details
Title: A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
Authors: Ang YLE; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore., Ho GF; University of Malaya Medical Centre, Kuala Lumpur, Malaysia., Soo RA; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore., Sundar R; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tan SH; OncoCare Cancer Centre, Singapore, Singapore., Yong WP; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore., Ow SGW; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lim JSJ; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore., Chong WQ; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore., Soe PP; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore., Tai BC; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore., Wang L; Cancer Science Institute, National University of Singapore, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Goh BC; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore. csilsc@nus.edu.sg.; Cancer Science Institute, National University of Singapore, Singapore, Singapore. csilsc@nus.edu.sg.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. csilsc@nus.edu.sg.
Source: BMC cancer [BMC Cancer] 2020 Nov 17; Vol. 20 (1), pp. 1118. Date of Electronic Publication: 2020 Nov 17.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33203399
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ang+YLE%22">Ang YLE</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.<br /><searchLink fieldCode="AU" term="%22Ho+GF%22">Ho GF</searchLink>; University of Malaya Medical Centre, Kuala Lumpur, Malaysia.<br /><searchLink fieldCode="AU" term="%22Soo+RA%22">Soo RA</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Sundar+R%22">Sundar R</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+SH%22">Tan SH</searchLink>; OncoCare Cancer Centre, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Yong+WP%22">Yong WP</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ow+SGW%22">Ow SGW</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+JSJ%22">Lim JSJ</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chong+WQ%22">Chong WQ</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.<br /><searchLink fieldCode="AU" term="%22Soe+PP%22">Soe PP</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.<br /><searchLink fieldCode="AU" term="%22Tai+BC%22">Tai BC</searchLink>; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Cancer Science Institute, National University of Singapore, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Goh+BC%22">Goh BC</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore.; Cancer Science Institute, National University of Singapore, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+SC%22">Lee SC</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Level 7, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore. csilsc@nus.edu.sg.; Cancer Science Institute, National University of Singapore, Singapore, Singapore. csilsc@nus.edu.sg.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. csilsc@nus.edu.sg.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2020 Nov 17; Vol. 20 (1), pp. 1118. <i>Date of Electronic Publication: </i>2020 Nov 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33203399
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-020-07616-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1118
    Titles:
      – TitleFull: A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ang YLE
      – PersonEntity:
          Name:
            NameFull: Ho GF
      – PersonEntity:
          Name:
            NameFull: Soo RA
      – PersonEntity:
          Name:
            NameFull: Sundar R
      – PersonEntity:
          Name:
            NameFull: Tan SH
      – PersonEntity:
          Name:
            NameFull: Yong WP
      – PersonEntity:
          Name:
            NameFull: Ow SGW
      – PersonEntity:
          Name:
            NameFull: Lim JSJ
      – PersonEntity:
          Name:
            NameFull: Chong WQ
      – PersonEntity:
          Name:
            NameFull: Soe PP
      – PersonEntity:
          Name:
            NameFull: Tai BC
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Goh BC
      – PersonEntity:
          Name:
            NameFull: Lee SC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 11
              Text: 2020 Nov 17
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1